TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns September 22, 1995
TCL Archive In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas January 1, 1993
TCL Archive “The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts” October 28, 1994
